U.S. pharma huge copyright scrapped two experimental weight loss supplements last calendar year—a at the time-every day pill, lotiglipron, because of elevated liver enzymes along with a two times-everyday pill, danuglipron, on account of robust side effects—but CEO Albert Bourla has